Veröffentlichungen
Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer
Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.
- [o.028] p53 Involvement in the Control of Murine Hair Follicle Regression (0)
- [o.027] p53 Is Essential for Chemotherapy-induced Hair Loss (0)
- [o.539] Patient-centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA-EAACI approach (0)
- [o.589] Patient-reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice (0)
- [o.264] Patients with chronic cold urticaria may benefit from doxycycline therapy (2)
- [o.535] Patients with chronic spontaneous urticaria who have wheals, angioedema, or both, differ demographically, clinically, and in response to treatment – results from CURE (2)
- [o.066] Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds (0)
- [o.509] Patients with hereditary angioedema and their treatment patterns in Germany: a Delphi consensus study (0)
- [o.031] Pattern analysis of human cutaneous mast cell populations by total body surface mapping (2)
- [o.343] Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings (0)
- [o.036] Peltier effect–based temperature challenge: An improved method for diagnosing cold urticaria (2)
- [o.513] Pharmacokinetic equivalence of CT-P39 and reference omalizumab in healthy individuals: a randomized double-blind, parallel-group, phase 1 trial (0)
- [o.007] Pharmacological Disruption of Hair Follicle Pigmentation by Cyclophosphamide as a Model for Studying the Melanocyte Response to and Recovery from Cytotoxic Drug Damage In Situ. (0)
- [o.516] Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis (0)
- [o.516a] Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis (Suppl. Phase 2 astegolimab AD) (0)
- [o.025] Phenotypical characterization of c-kit receptor deficient mouse femora using non-destructive high-resolution imaging techniques and biomechanical testing (0)
- [o.605] Plasma proteomics analysis of patients with chronic spontaneous urticaria reveals significant associations with key disease characteristics but not with response to omalizumab treatment (0)
- [o.149] Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation (0)
- [o.195] Polidocanol inhibits cowhage - but not histamine-induced itch in humans (0)
- [o.568] Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria (0)
(Last update: 06.2026)
| Number of original publications in peer-reviewed journals: | 662 |
| Number of reviews in peer-reviewed journals: | 231 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 893 |
| Cumulative IF for original publications in peer-reviewed journals: | 4768.99 |
| Cumulative IF for reviews in peer-reviewed journals: | 1703.12 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 6472.11 |
| Total number of citations: 45.522, h-index: 109 (Web of Science Juli 2025) | 45522 |
Download-Information
Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.